|Share on Facebook Facebook||Share on StumbleUpon StumbleUpon|
|Share on LinkedIn LinkedIn||Submit on Reddit reddit|
|Tweet Twitter||Pin it Pinterest|
|Share on Google+ Google+||Share on Digg Digg|
|Post to Tumblr Tumblr||Share on Delicious Delicious|
Welcome to VanEck
VanEck is a global investment manager with offices around the world. To help you find content that is suitable for your investment needs, please select your country and investor type.
As active managers continue to underperform U.S. equity benchmarks, we look at the importance of moats and valuations to the Morningstar® Wide Moat Focus IndexSM ’s performance and highlight its most undervalued constituents.
The latest quarterly review of the Morningstar Wide Moat Focus Index continues the key trends of the year: the shift away from big tech, tech and health care sector weight increases and an all-time high in value exposure.
The S&P 500 Index is positive for the year so far, despite more than half of its constituents posting negative total returns. Are certain sectors becoming far too overvalued?
The long standing healthcare overweight in the Morningstar Wide Moat Focus Index goes beyond patent protection to include the ability of large pharmaceutical and biotech companies to innovate.
Our latest moat investing webinar explored how the Morningstar Wide Moat Focus Index’s FAANG underweight impacts performance as well as the index’s long-term performance trends.
Switching Costs Build Moats and Retain Customers
Intangible Assets: The Leading Source of Moats
Network Effect: A Proven Way to Create a Moat
Cost Leadership Provides Market Control
Efficient Scale: Moats with Natural Monopoly
Boeing and Bank of America Headline March Review
Will These Tech Stock Valuations Last?
Defensive Positioning into 2020: Solving Your U.S. Large Cap Equity Problem
The Moat Stocks that Powered 2019 Outperformance
More of the Same (Good) Thing in Moat Investing
This website is published in the United States for residents of specified countries. Investors are subject to securities and tax regulations within their applicable jurisdictions that are not addressed on this website. Nothing on this website should be considered a solicitation to buy or an offer to sell shares of any investment in any jurisdiction where the offer or solicitation would be unlawful under the securities laws of such jurisdiction, nor is it intended as investment, tax, financial, or legal advice. Investors should seek such professional advice for their particular situation and jurisdiction.
Investing involves risk, including possible loss of principal. An investor should carefully consider investment objectives, risks, charges and expenses carefully before investing. This and other information can be found in the appropriate regulatory documents made available for a specified country as designated in this website.